Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Neuroreport
|
September 5, 2006
Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia
Allan V Kalueff, Pamela S Gallagher, Dennis L Murphy
Journal of Cell Science
|
February 27, 2014
The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility
Pamela S Gallagher, Sarah V Clowes Candadai, Richard G Gardner
Neuropharmacology
|
September 4, 2007
Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice
Meredith A Fox, Catherine L Jensen, Pamela S Gallagher, et al.
The Journal of Biological Chemistry
|
January 22, 2013
Substrate recognition in nuclear protein quality control degradation is governed by exposed hydrophobicity that correlates with aggregation and insolubility
Eric K Fredrickson, Pamela S Gallagher, Sarah V Clowes Candadai, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 6, 2013
Cellular maintenance of nuclear protein homeostasis
Pamela S Gallagher, Michelle L Oeser, Ayelet-chen Abraham, et al.
Molecular Biology of the Cell
|
April 22, 2011
A yeast model for polyalanine-expansion aggregation and toxicity
Catherine A Konopka, Melissa N Locke, Pamela S Gallagher, et al.
Nature Structural & Molecular Biology
|
April 25, 2018
Iron homeostasis regulates facultative heterochromatin assembly in adaptive genome control
Pamela S Gallagher, Madeline Larkin, Gobi Thillainadesan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, et al.
JCO Precision Oncology
|
September 11, 2020
Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings
Hisani N Horne, Donna Roscoe, E David Litwack, et al.
Microbiology Spectrum
|
January 12, 2022
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays
Ligia A Pinto, Ribhi M Shawar, Brendan O'Leary, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Neuroreport
|
September 5, 2006
Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia
Allan V Kalueff, Pamela S Gallagher, Dennis L Murphy
Journal of Cell Science
|
February 27, 2014
The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility
Pamela S Gallagher, Sarah V Clowes Candadai, Richard G Gardner
Neuropharmacology
|
September 4, 2007
Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice
Meredith A Fox, Catherine L Jensen, Pamela S Gallagher, et al.
The Journal of Biological Chemistry
|
January 22, 2013
Substrate recognition in nuclear protein quality control degradation is governed by exposed hydrophobicity that correlates with aggregation and insolubility
Eric K Fredrickson, Pamela S Gallagher, Sarah V Clowes Candadai, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 6, 2013
Cellular maintenance of nuclear protein homeostasis
Pamela S Gallagher, Michelle L Oeser, Ayelet-chen Abraham, et al.
Molecular Biology of the Cell
|
April 22, 2011
A yeast model for polyalanine-expansion aggregation and toxicity
Catherine A Konopka, Melissa N Locke, Pamela S Gallagher, et al.
Nature Structural & Molecular Biology
|
April 25, 2018
Iron homeostasis regulates facultative heterochromatin assembly in adaptive genome control
Pamela S Gallagher, Madeline Larkin, Gobi Thillainadesan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, et al.
JCO Precision Oncology
|
September 11, 2020
Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings
Hisani N Horne, Donna Roscoe, E David Litwack, et al.
Microbiology Spectrum
|
January 12, 2022
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays
Ligia A Pinto, Ribhi M Shawar, Brendan O'Leary, et al.
Page
of 1